Ensysce Biosciences Inc (ENSC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $8.14M
Last updated: Nov 17, 2026 at 11:03 AM ET
Ensysce Biosciences Inc (ENSC) Competitors
The companies most similar to Ensysce Biosciences are Dare Bioscience (DARE), Exicure (XCUR) and Soligenix (SNGX). By market cap, Ensysce Biosciences ranks 4th of the 13 companies on this page; Dare Bioscience (DARE) is the largest at $12.93M.
Peer Comparison
ENSC's ROIC of -260.6% is above the peer median of -783.6%, and its revenue growth of -15.1% is below the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Ensysce Biosciences (ENSC) | $8.14M | N/A | 1.2x | -280.5% | -260.6% | -15.1% | 0.00% |
| Dare Bioscience Inc (DARE) | $12.93M | N/A | 6.4x | 0.0% | N/A | 499.6% | 0.00% |
| Exicure Inc (XCUR) | $7.07M | N/A | N/A | 0.0% | N/A | 928.0% | 0.00% |
| Soligenix Inc. (SNGX) | $7.50M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Senti Biosciences Inc (SNTI) | $5.38M | N/A | 57.2x | 0.0% | 1039.8% | -100.0% | 0.00% |
| Enveric Biosciences Inc (ENVB) | $6.78M | N/A | 0.2x | 0.0% | N/A | -7.3% | 0.00% |
| Skye Bioscience, Inc. Common Stock (SKYE) | $4.83M | N/A | N/A | 0.0% | -3685.3% | 0.0% | 0.00% |
| Biovie Inc (BIVI) | $12.12M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| VistaGen Therapeutics Inc (VTGN) | $8.01M | N/A | 3.4x | 0.0% | N/A | -46.5% | 0.00% |
| Tempest Therapeutics Inc (TPST) | $7.64M | N/A | N/A | 0.0% | -783.6% | 0.0% | 0.00% |
| Psyence Biomedical Ltd. Common Shares (PBM) | $12.00M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| GT Biopharma Inc (GTBP) | $7.67M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CNS Pharmaceuticals Inc (CNSP) | $4.22M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $7.57M | N/A | 4.9x | 0.0% | -783.6% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Ensysce Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Dare Bioscience Inc (DARE) | Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. | DARE competitors |
| Exicure Inc (XCUR) | Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases... | XCUR competitors |
| Soligenix Inc. (SNGX) | Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. | SNGX competitors |
| Senti Biosciences Inc (SNTI) | Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology... | SNTI competitors |
| Enveric Biosciences Inc (ENVB) | Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. | ENVB competitors |
| Skye Bioscience, Inc. Common Stock (SKYE) | Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops... | SKYE competitors |
| Biovie Inc (BIVI) | BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. | BIVI competitors |
| VistaGen Therapeutics Inc (VTGN) | VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential... | VTGN competitors |
| Tempest Therapeutics Inc (TPST) | Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated... | TPST competitors |
| Psyence Biomedical Ltd. Common Shares (PBM) | Psyence Biomedical Ltd. (PBM) is an innovative biotechnology company focused on harnessing the therapeutic potential of psychedelic compounds to address mental... | |
| GT Biopharma Inc (GTBP) | GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its... | GTBP competitors |
| CNS Pharmaceuticals Inc (CNSP) | CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central... | CNSP competitors |
Frequently Asked Questions About ENSC
Who are Ensysce Biosciences' main competitors?
The companies most similar to Ensysce Biosciences include Dare Bioscience (DARE), Exicure (XCUR), Soligenix (SNGX), Senti Biosciences (SNTI) and Enveric Biosciences (ENVB), listed from the closest match.
Who is Ensysce Biosciences' biggest competitor?
Dare Bioscience (DARE) is both the largest of the similar companies at $12.93M and the closest match by business profile, size, sector and industry.
How does ENSC stock compare with its competitors?
ENSC's P/S is 1.2x against a peer median of 4.9x; its net margin is -280.5% against a peer median of 0.0%.
Which of Ensysce Biosciences' competitors pays a higher dividend?
Ensysce Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Ensysce Biosciences bigger than its competitors?
No. Ensysce Biosciences is 4th by market cap among the 13 companies on this page; the largest is Dare Bioscience (DARE) at $12.93M.
ENSC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors